Affordable Access

deepdyve-link deepdyve-link
Publisher Website

DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes.

Authors
Type
Published Article
Journal
Journal of Clinical Oncology
1527-7755
Publisher
American Society of Clinical Oncology
Publication Date
Volume
28
Issue
4
Pages
605–613
Identifiers
DOI: 10.1200/JCO.2009.23.4781
PMID: 20038729
Source
Medline
License
Unknown

Abstract

DNA methylation predicts overall and progression-free survival in MDS.

Statistics

Seen <100 times